SILVERCREST ASSET MANAGEMENT GROUP LLC

Holdings History for NovoCure Ltd - Ordinary Shares, no par value per share (NVCR)

Symbol: NVCR on Nasdaq
Investment type: Equity / Ordinary Shares, no par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.06%	+0%	$9,149,384	707,609	+1,534	+0.22%	$12.93	Q4 2025
30 Sep 2025	0.06%	+0.01%	$9,122,489	706,075	+165,778	+31%	$12.92	Q3 2025
30 Jun 2025	0.06%	+0.01%	$9,617,287	540,297	+82,269	+18%	$17.80	Q2 2025
31 Mar 2025	0.06%	+0.01%	$8,162,059	458,028	+109,721		$17.82	Q1 2025
31 Dec 2024	0.07%	-0.03%	$10,379,549	348,307	-147,804	-30%	$29.80	Q4 2024
30 Sep 2024	0.05%	+0.01%	$7,754,215	496,111	+110,701	+29%	$15.63	Q3 2024
30 Jun 2024	0.05%	+0.04%	$6,602,073	385,410	+385,410	NEW	$17.13	Q2 2024
31 Mar 2021		-0%	$0	0	-1,384	-100%	$11.74	Q1 2021
31 Dec 2020	0%	-0%	$239,000	1,384	-1,787	-56%	$172.69	Q4 2020
30 Sep 2020	0%	+0%	$353,000	3,171	+3,171	NEW	$111.32	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.